Cargando…

Estimating the Burden of Illness of Relapsed Follicular Lymphoma and Marginal Zone Lymphoma in Ontario, Canada

Background: Many patients with advanced follicular lymphoma (FL) and marginal zone lymphoma (MZL) relapse after first-line chemotherapy. Objective: To examine healthcare resource utilization (HCRU) and cost, treatment patterns, progression, and survival of patients with FL and MZL who relapse after...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuruvilla, John, Ewara, Emmanuel M., Elia-Pacitti, Julia, Ng, Ryan, Eberg, Maria, Kukaswadia, Atif, Sharma, Arushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216939/ https://www.ncbi.nlm.nih.gov/pubmed/37232810 http://dx.doi.org/10.3390/curroncol30050352

Ejemplares similares

Estimating the Associated Burden of Illness and Healthcare Utilization of Newly Diagnosed Patients Aged ≥65 with Mantle Cell Lymphoma (MCL) in Ontario, Canada
por: Anglin, Peter, et al.
Publicado: (2023)

Follicular lymphoma and marginal zone lymphoma: how many diseases?
por: Laurent, Camille, et al.
Publicado: (2022)

Chemotherapy-Free Management of Follicular and Marginal Zone Lymphoma
por: Ollila, Thomas A, et al.
Publicado: (2021)

Follicular lymphoma presenting like marginal zone lymphoma: A case report
por: Peng, Hao-Yu, et al.
Publicado: (2022)

Postibrutinib relapse outcomes for patients with marginal zone lymphoma
por: Epperla, Narendranath, et al.
Publicado: (2022)

Management of relapsed/refractory marginal zone lymphoma: focus on ibrutinib
por: Denlinger, Nathan M, et al.
Publicado: (2018)

Marginal zone lymphoma
por: Kimby, Eva
Publicado: (2018)

A study of the mutational landscape of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma
por: Ozawa, Michael G, et al.
Publicado: (2016)

Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review
por: Rivero, Andrea, et al.
Publicado: (2023)

Radiotherapy in marginal zone lymphoma
por: Deinbeck, Kristin, et al.
Publicado: (2013)

Transformation of low-grade follicular lymphoma with partial marginal zone differentiation: Two cases
por: Nalbandyan, Karen, et al.
Publicado: (2021)

The role of axicabtagene ciloleucel as a treatment option for patients with follicular/marginal zone lymphoma
por: Sandoval-Sus, Jose, et al.
Publicado: (2021)

Mantle cell lymphoma with features of marginal-zone lymphoma
por: Randen, Ulla, et al.
Publicado: (2011)

Splenic marginal zone lymphoma relapsing as miliary lung mottling: an unusual presentation
por: Mandal, Tanmoy, et al.
Publicado: (2018)

Use of anti-CD20 therapy in follicular and marginal zone lymphoma: a review of the literature
por: Juárez-Salcedo, Luis Miguel, et al.
Publicado: (2020)

Marginal zone lymphomas in HIV patients
por: Genet, Philippe, et al.
Publicado: (2012)

Splenic Marginal Zone Lymphoma With Histological Transformation to Hodgkin’s Lymphoma
por: Veeraballi, Sindhusha, et al.
Publicado: (2022)

PB2266: TRIAL IN PROGRESS: PHASE 3 TRIAL OF ODRONEXTAMAB PLUS LENALIDOMIDE VERSUS RITUXIMAB PLUS LENALIDOMIDE IN RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND MARGINAL ZONE LYMPHOMA (OLYMPIA-5)
por: Vitolo, Umberto, et al.
Publicado: (2023)

Infectious Aetiology of Marginal Zone Lymphoma and Role of Anti-Infective Therapy
por: Perrone, Salvatore, et al.
Publicado: (2016)

Relapsed/Refractory Hodgkin Lymphoma
por: Sheikh, Semira, et al.
Publicado: (2018)

The role of tazemetostat in relapsed/refractory follicular lymphoma
por: von Keudell, Gottfried, et al.
Publicado: (2021)

Primary extranodal marginal zone lymphoma – Epididymis
por: Rajaian, Shanmugasundaram, et al.
Publicado: (2011)

The genetic landscape of dural marginal zone lymphomas
por: Ganapathi, Karthik A., et al.
Publicado: (2016)

Unusual Course of Splenic Marginal Zone Lymphoma
por: Tun, Nay T., et al.
Publicado: (2013)

The Biology of Ocular Adnexal Marginal Zone Lymphomas
por: Johansson, Patricia, et al.
Publicado: (2022)

Deregulation of cellular signaling in marginal zone lymphoma
por: Du, Ming-Qing
Publicado: (2018)

Retrospective characterization of nodal marginal zone lymphoma
por: Stuver, Robert, et al.
Publicado: (2023)

Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study
por: Opat, Stephen, et al.
Publicado: (2023)

Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
por: Witlox, Willem J. A., et al.
Publicado: (2020)

P1103: INMIND: A PHASE 3 STUDY OF TAFASITAMAB PLUS LENALIDOMIDE AND RITUXIMAB VERSUS PLACEBO PLUS LENALIDOMIDE AND RITUXIMAB FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL) OR MARGINAL ZONE LYMPHOMA (MZL)
por: Sehn, L. H., et al.
Publicado: (2022)

P1158: REAL-WORLD TREATMENT PATTERNS AND ECONOMIC BURDEN OF PATIENTS WITH MARGINAL ZONE LYMPHOMA
por: Yang, K., et al.
Publicado: (2022)

Treatment selection for patients with relapsed or refractory follicular lymphoma
por: Skarbnik, Alan Z., et al.
Publicado: (2023)

A Rare Case of Splenic Marginal Zone B-Cell Lymphoma Mimicking Relapsing Polychondritis of the Ear
por: Huang, Gary J., et al.
Publicado: (2014)

Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study
por: Epperla, Narendranath, et al.
Publicado: (2022)

Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial
por: Scarfò, Lydia, et al.
Publicado: (2022)

Gastric Marginal Zone B Cell Lymphoma of the Duodenum
por: Ndzengue, A., et al.
Publicado: (2011)

Karyometric Comparison of Splenic and Gastric Marginal Zone Lymphomas
por: Styczeń, Magdalena, et al.
Publicado: (2012)

Marginal Zone Lymphoma Complicated by Protein Losing Enteropathy
por: Stanek, Nadine, et al.
Publicado: (2016)

Spontaneous splenic rupture due to marginal zone lymphoma
por: Yepuri, Natesh, et al.
Publicado: (2017)

Recent advances in understanding the biology of marginal zone lymphoma
por: Bertoni, Francesco, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bih3i7jt1l684q6ni76r12igj9